Open access · CC-BY
via OpenAlex
Nicotinamide treatment robustly protects from inherited mouse glaucoma
Pete A. Williams, Jeffrey M. Harder, Brynn H. Cardozo, Nicole E. Foxworth, Simon W. M. John
Communicative & Integrative Biology · 2018 · ▲ 96 citations
Abstract
Nicotinamide adenine dinucleotide (NAD) is a key molecule in several cellular processes and is essential for healthy mitochondrial metabolism. We recently reported that mitochondrial dysfunction(definition) is among the very first changes to occur within retinal ganglion cells during initiation of glaucoma in DBA/2J mice. Furthermore, we demonstrated that an age-dependent decline of NAD contributes to mitochondrial dysfunction and vulnerability to glaucoma. The decrease in NAD renders retinal ganglion cells vulnerable to a metabolic crisis following periods of high intraocular pressure. Treating mice with the NAD precursor nicotinamide (the amide form of vitamin B3) inhibited many age- and high intraocular pressure- dependent changes with the highest tested dose decreasing the likelihood of developing glaucoma by ∼10-fold. In this communication, we present further evidence of the neuroprotective effects of nicotinamide against glaucoma in mice, including its prevention of optic nerve excavation and axon loss as assessed by histologic analysis and axon counting. We also show analyses of age- and intraocular pressure- dependent changes in transcripts of NAD producing enzymes within retinal ganglion cells and that nicotinamide treatment prevents these transcriptomic changes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1080/19420889.2017.1356956
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Williams, P.A., Harder, J.M., Cardozo, B.H., Foxworth, N.E., & John, S.W.M. (2018). Nicotinamide treatment robustly protects from inherited mouse glaucoma. <em>Communicative & Integrative Biology</em>. https://doi.org/10.1080/19420889.2017.1356956
Vancouver
Williams PA, Harder JM, Cardozo BH, Foxworth NE, John SWM. Nicotinamide treatment robustly protects from inherited mouse glaucoma. Communicative & Integrative Biology. 2018. doi:10.1080/19420889.2017.1356956.
BibTeX
@article{pete2018Nicoti,
title = {Nicotinamide treatment robustly protects from inherited mouse glaucoma},
author = {Pete A. Williams and Jeffrey M. Harder and Brynn H. Cardozo and Nicole E. Foxworth and Simon W. M. John},
journal = {Communicative & Integrative Biology},
year = {2018},
doi = {10.1080/19420889.2017.1356956},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Ophthalmology 2023
Open access · CC-BY
Mitochondrial dysfunction in glaucomatous degeneration
bioRxiv (Cold Spring Harbor Laboratory) 2024
Preprint · CC-BY
Oral supplementation with Nicotinamide Riboside treatment protects RGCs in DBA/2J mouse model
Acta Neuropathologica Communications 2023
Open access · CC-BY
NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve
Stem Cells Translational Medicine 2017
Open access · CC-BY
Bone Marrow-Derived Mesenchymal Stem Cells-Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA-Dependent Mechanisms
Aging Cell 2023
Open access · CC-BY
Long‐term NAD + supplementation prevents the progression of age‐related hearing loss in mice
Biotechnology Journal 2024
Open access · CC-BY